The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Daniel W. Coyne

Washington University School of Medicine

660 S. Euclid Avenue

Campus Box 8129

St. Louis

USA

[email]@im.wustl.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8129, St. Louis, USA. 2003 - 2010
  • Washington University School of Medicine, St Louis, MO 63110, USA. 2008 - 2009
  • Department of Internal Medicine, Renal Division, and the Chromalloy American Kidney Center at Washington University School of Medicine, St Louis, USA. 2002 - 2009

References

  1. It's time to compare anemia management strategies in hemodialysis. Coyne, D.W. Clin. J. Am. Soc. Nephrol (2010) [Pubmed]
  2. Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease. Coyne, D.W. Expert. Opin. Pharmacother (2009) [Pubmed]
  3. Managing anemia in for-profit dialysis chains: when ethics and business conflict. Coyne, D.W. Semin. Dial (2009) [Pubmed]
  4. Seeking safe and efficacious anemia management. Coyne, D.W., Brennan, D.C. Semin. Dial (2009) [Pubmed]
  5. Comment on "Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels?". Coyne, D.W., Trout, J.R., Kapoian, T. Nat. Clin. Pract. Nephrol (2008) [Pubmed]
  6. Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease. Coyne, D.W. Nat. Clin. Pract. Nephrol (2008) [Pubmed]
  7. Introduction to "A road map for intravenous iron and anemia management: preparing for the future". Coyne, D.W. Am. J. Kidney Dis. (2008) [Pubmed]
  8. A comprehensive vision for intravenous iron therapy. Coyne, D.W. Am. J. Kidney Dis. (2008) [Pubmed]
  9. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. Coyne, D.W., Kapoian, T., Suki, W., Singh, A.K., Moran, J.E., Dahl, N.V., Rizkala, A.R. J. Am. Soc. Nephrol. (2007) [Pubmed]
  10. Influence of industry on renal guideline development. Coyne, D.W. Clinical J. American Society Nephrology : Cjasn (2007) [Pubmed]
  11. Practice recommendations based on low, very low, and missing evidence. Coyne, D.W. Clinical J. American Society Nephrology : Cjasn (2007) [Pubmed]
  12. Challenging the boundaries of anemia management: a balanced approach to i.v. iron and EPO therapy. Coyne, D. Kidney Int. Suppl. (2006) [Pubmed]
  13. Iron indices: what do they really mean?. Coyne, D. Kidney Int. Suppl. (2006) [Pubmed]
  14. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Coyne, D.W., Adkinson, N.F., Nissenson, A.R., Fishbane, S., Agarwal, R., Eschbach, J.W., Michael, B., Folkert, V., Batlle, D., Trout, J.R., Dahl, N., Myirski, P., Strobos, J., Warnock, D.G. Kidney Int. (2003) [Pubmed]
  15. Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients. Coyne, D.W., Grieff, M., Ahya, S.N., Giles, K., Norwood, K., Slatopolsky, E. Am. J. Kidney Dis. (2002) [Pubmed]
 
WikiGenes - Universities